Chief Healthcare Executive April 9, 2024
Research studies often fail to include enough participants from minority groups. Jenn Higgins of Guardant Health talks about getting a diverse mix for the ECLIPSE trial.
Healthcare leaders are increasingly focused on improving the diversity of clinical trials, and it’s an area where companies and researchers need to do better.
It’s important to give consideration to diversity in trials, and healthcare companies, universities and researchers must also consider factors that could be hampering efforts to find a greater mix of participants, says Jenn Higgins, senior vice president of global public affairs at Guardant Health.
“I think there’s a need and interest to make sure that when you do a clinical trial, that it’s representative of the overall population. But that’s...
Today's Sponsors
Today's Sponsor